Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Sensorion reports results from phase I study of SENS-218 for inner ear lesions

Sep. 8, 2016

Auris Medical's phase III trial of Keylizen does not meet its two coprimary efficacy endpoints

Aug. 19, 2016

FDA's clinical hold on CGF-166 lifted

July 26, 2016

Auris Medical obtains fast track designation for Keyzilen

July 19, 2016

Strekin begins phase II study of STR-001

April 29, 2016

Boehringer Ingelheim and Kyoto University to investigate new drugs for sensorineural hearing loss

April 5, 2016

Otonomy launches Otiprio in U.S.

March 3, 2016

Oricula Therapeutics receives NIH grant to support development of ORC-13661

Feb. 4, 2016

3D-printed biomimetic tympanic membrane shows similar acoustic properties to human eardrum

Jan. 26, 2016

Sensorion cleared to initiate phase I trial of SENS-218 in U.K.

Jan. 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...